RESCRIPTOR (delavirdine) Patient Assistance Program
Don’t let the high cost of brand legacy HIV NNRTI therapy disrupt your treatment. We help eligible patients access Rescriptor (delavirdine) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Rescriptor (delavirdine) is FDA-approved for HIV-1 infection in adults in combination with other antiretrovirals. It is a first-generation NNRTI with three-times-daily dosing. NOTE: No longer recommended in current HIV guidelines — superseded by modern INSTI-based regimens.
- Without assistance, Rescriptor costs commonly run approximately $300–$500 per 30-day supply.
- Through AffordMyPrescriptions, qualifying patients can access Rescriptor for a flat $69.95 per month.
- Modern HIV guidelines strongly recommend INSTI-based regimens (Biktarvy, Triumeq, Dovato) instead. Delavirdine is now rarely used. Patients on Rescriptor should discuss switching to modern regimens with HIV provider for better efficacy, safety, and adherence.
What Is Rescriptor Prescription Assistance Program?
Rescriptor PAP rarely needed in 2026.
Eligibility, HIV provider coordination.
AffordMyPrescriptions eliminates that burden. $69.95/month advocacy.
Pharmacy Price Comparison
- Rescriptor $300–$500/month. Modern HIV regimens strongly preferred:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$480 | Save substantially |
| CVS Pharmacy | ~$500 | Save substantially |
| Walmart | ~$340 | Save substantially |
| Costco | ~$320 | Save substantially |
Modern HIV regimens | Generally preferred | Better outcomes |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Rescriptor Prescription Program?
Strongly recommend discussing switch to modern HIV regimen (Biktarvy, Triumeq, Dovato) with HIV provider. Rescriptor outdated.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Rescriptor:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $300–$500 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Rescriptor assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Rescriptor Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Rescriptor:
Rescriptor (delavirdine) is first-generation NNRTI from late 1990s. Three-times-daily dosing, multiple drug interactions, modest virologic potency. No longer in HIV guidelines — patients still on Rescriptor should be switched to modern regimens.
How Promacta Works:
NNRTI binds non-active site of HIV-1 reverse transcriptase causing conformational change preventing function. Older NNRTIs (delavirdine, nevirapine, efavirenz) replaced in modern regimens.
Three-times-daily dosing impractical. Better options: dolutegravir-based or bictegravir-based regimens (once-daily single tablets — Triumeq, Dovato, Biktarvy).
Form and use:
Rescriptor TID — outdated dosing pattern.
Generic availability:
Generic delavirdine may be available but rarely prescribed. Modern preferred options: Biktarvy (BIC/FTC/TAF — most prescribed), Triumeq (DTG/ABC/3TC), Dovato (DTG/3TC two-drug). All once-daily single tablets with high resistance barriers.
Warnings:
Severe skin reactions (rash including Stevens-Johnson syndrome), hepatotoxicity, drug interactions (CYP3A4 inhibitor — many interactions), immune reconstitution syndrome.
FAQ (Frequently Asked Questions)
Cost?
$300–$500/month. Modern HIV regimens generally preferred over Rescriptor.
Should I switch?
Yes — strongly consider switching to modern regimen. Biktarvy, Triumeq, Dovato all once-daily single tablets with better efficacy, tolerability, fewer interactions. Discuss with HIV provider.
Why is Rescriptor outdated?
Three-times-daily dosing impractical, multiple drug interactions, lower potency than modern INSTIs. Removed from HIV guidelines years ago.
Generic available?
Generic delavirdine may exist but rarely prescribed. Generic modern HIV components in combinations available.
Denied?
Switch to modern HIV regimen with PAP (Biktarvy, Triumeq, Dovato have own PAPs). State ADAP.
Take Control of Your Medication Costs
Rescriptor outdated — discuss switching to modern HIV regimen with provider. Check eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.